Vinorelbine Te Arai 20mg, 30mg and 80mg oral, soft gel capsules is indicated to treat a number of cancer types including lung and breast cancer. (1)

​

Vinorelbine Te Arai is Fully funded without restriction. (2) Oral vinorelbine is more convenient than intravenous injectable vinorelbine in that it can be taken by people in the community, outside of hospital or clinic infusion services. This reduces capacity pressure on infusion services, reduces medicine administration costs and is preferred by people requiring vinorelbine treatment. (3)